Crossmark

Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives

Published Online: 2021-06-09

Published Print: 2021-12

Authors

Yan, Kexin

Rawle, Daniel J.

Le, Thuy T.

Suhrbier, Andreas https://orcid.org/0000-0001-8986-9025
Funding

Funding for this research was provided by:

National Health and Medical Research Council (APP1173880)

QIMR Berghofer Medical Research Institute
License Information

Text and Data Mining valid from 2021-06-09

Version of Record valid from 2021-06-09
More Information

Article History

Received: 10 February 2021

Accepted: 27 May 2021

First Online: 9 June 2021

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current